With this CME Outfitters Briefcase activity, we will delve into a patient case interaction, set in a primary care/women’s health setting, to explore critical concepts in migraine management. Despite advancements, unmet needs persist for patients with migraine, especially among women, marginalized communities, and those who seek care in emergency settings. Addressing these disparities requires prioritizing accurate diagnosis and the implementation of appropriate pharmacotherapy, while considering social determinants of health and access to care.
Given the recent position statement from the American Headache Society endorsing calcitonin gene-related peptide receptor antagonists (CGRP-RAs) for first-line prevention of migraine, it is crucial for primary care practitioners to ensure all patients have access to the latest, evidence-based treatments. In this activity, expert faculty will address the educational needs of non-migraine specialist healthcare practitioners. We will discuss common challenges faced by the multidisciplinary care team, including shared decision-making practices to determine the best treatment options for patients.
At the conclusion of this activity, learners will be able to better:
This activity is supported by independent educational grants from AbbVie and Pfizer Inc.
HCPs involved in the management of adults with migraine, including primary care, women’s health, and EM physicians, physician associates (PAs), nurse practitioners (NPs), and nurses
In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CME Outfitters, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is designated for 0.75 contact hours.
California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.
This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education Credit for learning and change.
CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 10/24/2025. PAs should only claim credit commensurate with the extent of their participation.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Dr. Ailani reports the following financial relationships:
Advisory Board: LinPharma; Merz Pharma; Pfizer Inc.; and Vectura Fertin Pharma, Inc.
Consultant: AbbVie Inc.; AEON Biopharma, Inc.; Dr. Reddy Laboratories; eNeura Inc.; Gore; Ispen Pharma; Lilly; LinPharma; Lundbeck; Merz Pharma; Pfizer Inc.; Satsuma Pharmaceuticals, Inc.; Scilex Pharmaceuticals; and Tonix Pharmaceuticals
Grants: Clinical Trials (Grant to institution): AbbVie Inc.; Ispsen Pharma; Lundbeck; and Parema
Other financial or material support: Editorial Boards/Steering Committee: SELF Magazine (medical editor)
Dr. Hutchinson reports the following financial relationships:
Advisory Board: AbbVie Inc.; Lundbeck; and Pfizer Inc.
Speakers Bureau: AbbVie Inc.; Lundbeck; Pfizer Inc.; and Scilex Pharmaceuticals
The following individuals have no financial relationships to disclose:
Rebecca Vargas-Jackson, MD (Peer Reviewer)
Elizabeth Naber, MSN, RN, CCRN-K, CNRN, TCRN (Peer Reviewer)
Mary Gleason, PhD, CHCP (Planning Committee)
Erin Spencer, PharmD (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)
Call us at 877.CME.PROS (877.263.7767).
BC-129-102424-90